Ozempic, Wegovy, and other brand-name GLP-1s are available, with transparent pricing disclosed upfront
More from the series Subscribe: Apple Podcasts Spotify Injectable peptide therapy, a controversial wellness trend that caught fire online in 2025, shows no signs of slowing down in 2026, despite an overwhelming lack of safety data
Before bed: damage limitation Youre now at the damage limitation stage following your night out on the drink
To reconcile the findings that both GIPR antagonists and GIPRAs reduce body weight, it is possible that physiological GIPR activity plays a permissive role in adipose tissue synthesis, while pharmacologically enhanced GIPR activity may reduce body weight through a different mechanism in the brain
Any claim that one outperforms the other is cross-trial inference, not a measured result
Yes, ipamorelin is often part of a broader wellness plan